BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)
-
Upload
bigdataeurope -
Category
Healthcare
-
view
20 -
download
2
Transcript of BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)
![Page 1: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/1.jpg)
Supriyo ChatterjeaData Science, Philips Research
13-Dec 2017
BigMedilyticsBig Data for Medical Analytics
![Page 2: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/2.jpg)
The founding fathers of Philips
Frederik Gerard Anton
Philips, a born innovator
For over 125 years, we have been improving people’s lives with a steady flow of ground-breaking innovations
![Page 3: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/3.jpg)
We strive to make the world healthier and more sustainable through innovation
We’re aiming to improve the lives of
3 billionpeople a year
by 2025
![Page 4: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/4.jpg)
At Philips, we take a holistic view of people’s health journeys, starting with healthy living and prevention, precision diagnosis and personalized treatment, through to care in the home – where the cycle to healthy living begins again.
Ready to take on the healthcare challenge
Healthy living Prevention Diagnosis Treatment Home care
Connected care and health informatics
![Page 5: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/5.jpg)
Aging populations and the rise of chronic illnesses
DigitizationIncreasing consumer engagement
Global resource constraints
Four profound trends are shaping the future of health technology
In 2060 Healthcare sector: 30% of EU’s GDPChronic diseases result in loss of 3.4million potential productive years; equivalent to €115 billion annually
Healthcare sector: 10% of EU’s GDPEU-28’s total healthcare spending: €1.39 trillion
![Page 6: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/6.jpg)
Aging populations and the rise of chronic illnesses
DigitizationIncreasing consumer engagement
Global resource constraints
Four profound trends are shaping the future of health technology
Healthcare sector: 10% of EU’s GDPEU-28’s total healthcare spending: €1.39 trillion
In 2060 Healthcare sector: 30% of EU’s GDPChronic diseases result in loss of 3.4million potential productive years; equivalent to €115 billion annually
![Page 7: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/7.jpg)
Aging populations and the rise of chronic illnesses
DigitizationIncreasing consumer engagement
Global resource constraints
Four profound trends are shaping the future of health technology
Quality
Cost Access
Quality: Determined by efficacy, value and efficiency
Access: Those who can receive care when needed
Cost: Actual expense of patient care
Effectiveness of healthcare system:
Healthcare sector: 10% of EU’s GDPEU-28’s total healthcare spending: €1.39 trillion
In 2060 Healthcare sector: 30% of EU’s GDPChronic diseases result in loss of 3.4million potential productive years; equivalent to €115 billion annually
![Page 8: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/8.jpg)
Aging populations and the rise of chronic illnesses
DigitizationIncreasing consumer engagement
Global resource constraints
Four profound trends are shaping the future of health technology
Quality
Cost Access
Quality: Determined by efficacy, value and efficiency
Access: Those who can receive care when needed
Cost: Actual expense of patient care
Effectiveness of healthcare system:
Productivity
Healthcare sector: 10% of EU’s GDPEU-28’s total healthcare spending: €1.39 trillion
In 2060 Healthcare sector: 30% of EU’s GDPChronic diseases result in loss of 3.4million potential productive years; equivalent to €115 billion annually
![Page 9: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/9.jpg)
Aging populations and the rise of chronic illnesses
DigitizationIncreasing consumer engagement
Global resource constraints
Four profound trends are shaping the future of health technology
Healthcare sector: 10% of EU’s GDPEU-28’s total healthcare spending: €1.39 trillion
In 2060 Healthcare sector: 30% of EU’s GDPChronic diseases result in loss of 3.4million potential productive years; equivalent to €115 billion annually
Creates more opportunities to focus on healthy living and prevention
![Page 10: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/10.jpg)
Aging populations and the rise of chronic illnesses
DigitizationIncreasing consumer engagement
Global resource constraints
Four profound trends are shaping the future of health technology
Healthcare sector: 10% of EU’s GDPEU-28’s total healthcare spending: €1.39 trillion
In 2060 Healthcare sector: 30% of EU’s GDPChronic diseases result in loss of 3.4million potential productive years; equivalent to €115 billion annually
Extract knowledge from already existing large amounts of generated medical dataBig Data: Medical data currently estimated around 1 Zettabyte (152 Million years, UHD, 8K video)
Creates more opportunities to focus on healthy living and prevention
![Page 11: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/11.jpg)
Focus: Not on development of state-of-the-art algorithms. Instead focus on improving productivity of Healthcare sector by applying and adapting state-of-the-art Big Data techniques/algorithms.
Big Data PPP: Large Scale Pilot actions in sectors best benefitting from data-driven innovation
Opportunity to demonstrate how Europe’s Healthcare sector can be transformed in order to meet the changing needs of her citizens.
Technology isn’t the only thing that matters! Understanding all the needs of the sector are the key to success!
![Page 12: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/12.jpg)
BigMedilytics aims to use state-of-the-art Big Data technologies in order to improve the productivity
of the Healthcare sector by at least 20%, by reducing cost to the patient, improving quality
through better patient outcomes and delivering better access – simultaneously.
![Page 13: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/13.jpg)
Approach
Maximize impact
What are the key disease groups that will have the greatest burdens on society in the years to come?
![Page 14: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/14.jpg)
Percentage of deaths from non-communicable diseases in Europe
Cardiovascular disease
Cancer
Kidney disease
Diabetes
Respiratory disease
Neuropsychiatric conditions
Digestive diseases
Oral conditions
Other (e.g. injury)
59%
19%
BigMedilytics covers all the major disease groups in Europe which
cause 78% of the deaths:
• Cardiovascular disease• Cancer
• Breast cancer• Lung cancer• Prostate cancer
• Chronic respiratory disease• Diabetes• Kidney disease• Comorbidities
2 themes
Population Health& Chronic Disease Management
Oncology
![Page 15: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/15.jpg)
Approach
Maximize impact
What are the key disease groups that will have the greatest burdens on society in the years to come?
Temporal aspect? The trajectory of a patient.
![Page 16: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/16.jpg)
Healthcare continuum
THEME 3: Industrialization of healthcare
THEME 1: Population Health & Chronic Disease Management
THEME 2: Oncology
![Page 17: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/17.jpg)
Approach
Maximize impact
What are the key disease groups that will have the greatest burdens on society in the years to come?
Temporal aspect? The trajectory of a patient.
What are the (tech/non-tech) hurdles preventing us from transforming healthcare?
![Page 18: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/18.jpg)
Challenges: Technical/non-technical
Enabling collaborative innovation across all key players in the Healthcare and Data Value Chains• Patients• Healthcare Providers• Payers• Vendors (Medical diagnostics and
Services, Pharmaceuticals, HealthcareIT)• Knowledge Institutions
![Page 19: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/19.jpg)
Challenges: Technical/non-technical
Enabling collaborative innovation across all key players in the Healthcare and Data Value Chains• Patients• Healthcare Providers• Payers• Vendors (Medical diagnostics and
Services, Pharmaceuticals, HealthcareIT)• Knowledge Institutions
LegalEthics
Business Model Innovation
Scale concepts across Europe
![Page 20: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/20.jpg)
Approach
Maximize impact
What are the key disease groups that will have the greatest burdens on society in the years to come?
Temporal aspect? The trajectory of a patient.
What are the (tech/non-tech) hurdles preventing us from transforming healthcare?
What are the key industries/ (experienced!!) companies that can help improve Healthcare in Europe?
![Page 21: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/21.jpg)
BigMedilytics35 partners across 12 countries
Healthcare providersIncliva (ES)Karolinska (SE)ErasmusMC (NL)Rotunda Hospital (IE)P. Hierro Hospital (ES)Charite (DE)OLVG (NL)ETZ (NL)Essen Hospital (DE)Curie (FR)MUW (A)
HealthTech/ITPhilips (NL)IBM (IL)ATOS (ES)Huawei (DE)Optimedis (DE)
PayersAXA (FR)Achmea (NL)AOK (DE)
Research InstitutesDFKI (DE)ITI (ES)TNO (NL)NCSR-D (GR)VTT (FI)HPI (DE)
SMENissatech (RS)MymHealth (UK)
UniversitiesTU/e (NL)UPM (ES)iBMG (NL)Uni. Of Southampton (UK)LUH (DE)
PharmaAstraZeneca (UK)
SMEsNissatech (RS)MyMHealth (UK)ContextFlow (A)ATC (GR)
![Page 22: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/22.jpg)
Approach
Maximize impact
What are the key disease groups that will have the greatest burdens on society in the years to come?
Temporal aspect? The trajectory of a patient.
What are the (tech/non-tech) hurdles preventing us from transforming healthcare?
How can we make sure that our concepts scale?
![Page 23: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/23.jpg)
BigMedilytics12 pilots across 3 themes
BigMedilytics Pilots
Population Health & ChronicDisease Management
WP2 Leader: Incliva
OncologyWP3 Leader: Philips
Industrializing Healthcare ServicesWP4 Leader: Philips
1. ComorbiditiesPilot Leader: Incliva
3. DiabetesPilot Leader: Huawei
5. Heart FailurePilot Leader: EMC
2. Kidney DiseasePilot Leader: Charite
4. COPD/AsthmaPilot Leader: Southampton
5. Heart FailurePilot Leader: EMC
6. Prostate cancerPilot Leader: Philips
7. Lung cancerPilot Leader: NCSR-D
8. Breast cancerPilot Leader: IBM
Hyper-AcuteWorkflows
12. RadiologyWorkflows
11. Asset ManagementPilot Leader: OLVG
9. StrokePilot Leader: ETZ
10. SepsisPilot Leader: Incliva
Pilot Leader: ContextFlow
![Page 24: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/24.jpg)
Approach
Maximize impact
What are the key disease groups that will have the greatest burdens on society in the years to come?
Temporal aspect? The trajectory of a patient.
What are the (tech/non-tech) hurdles preventing us from transforming healthcare?
What are the key industries/ (experienced!!) companies that can help improve Healthcare in Europe?
How can we make sure that our concepts scale?
Availability of data and platforms
![Page 25: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/25.jpg)
Characteristics of datasets
Health records of more than 11 million patients across 8 countries in Europe• Clinical data• Medical images• Laboratory data• Prescription data• Claims data
Streaming data from IoTconnected devices at more than a million records per hour
Patient generated data from mobile apps
![Page 26: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/26.jpg)
Flexible architecture
![Page 27: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/27.jpg)
Approach
Maximize impact
What are the key disease groups that will have the greatest burdens on society in the years to come?
Temporal aspect? The trajectory of a patient.
What are the (tech/non-tech) hurdles preventing us from transforming healthcare?
What are the key industries/ (experienced!!) companies that can help improve Healthcare in Europe?
How can we make sure that our concepts scale?
Availability of data and platforms
How can we leave behind a lasting legacy?
![Page 28: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/28.jpg)
Best practices
Technology
Health Policy& Regulatory
Businessmodels
![Page 29: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/29.jpg)
Approach
Maximize impact
What are the key disease groups that will have the greatest burdens on society in the years to come?
Temporal aspect? The trajectory of a patient.
What are the (tech/non-tech) hurdles preventing us from transforming healthcare?
What are the key industries/ (experienced!!) companies that can help improve Healthcare in Europe?
How can we make sure that our concepts scale?
Availability of data and platforms
How can we leave behind a lasting legacy?
![Page 30: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/30.jpg)
Network of 104 partners
• Workshops with External Exploitation Partners
• Demonstrate early stage pilots and test feasibility for all three themes
• Gather feedback from External Exploitation partners
• Collaborate with External Exploitation partners to test concepts on a larger scale throughout Europe
![Page 31: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/31.jpg)
Pilot descriptionsPilot 1: Comorbidities
Primary care Secondary care
5 million patientsmonitored over a 5-year period
Low risk
High risk
Pilot Leader: Incliva, ES
![Page 32: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/32.jpg)
Pilot descriptionsPilot 5: Prostate cancer
Integrated data
Derive treatment and VBHC related quality outcome
measures
Pilot Leader: Philips, NL
Radiology
Urology
Pathology
Financial(Diagnostics+Treatment)
Predict outcome after primary intervention
![Page 33: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/33.jpg)
Pilot descriptionsPilot 9: Stroke workflows
Integrated data Derive workflows
Pilot Leader: Elisabeth TweeSteden Ziekenhuis, NL
EMR
Lab
Staff
Real-time Location
Predict workflow performance
![Page 34: BDE SC1 Workshop 3 - BigMedilytics Overview (Supriyo Chatterjea)](https://reader034.fdocuments.in/reader034/viewer/2022042707/5a6614a97f8b9a25258b483d/html5/thumbnails/34.jpg)